Two haemophilia patients with inhibitors who became ambulatory after physiotherapy under haemostatic cover with bypassing agents

Haemophilia

Volumn 19, Issue 5, 2013, Pages

  Kajiwara, M ^a,c   Shima, M ^b   Yoshioka, A ^b  

^a National Hospital Organization   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c Department of Paediatrics   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ARTHROPATHY; BLEEDING; CASE REPORT; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; FAMILY HISTORY; HEMOPHILIA A; HEMOSTASIS; HUMAN; JOINT RADIOGRAPHY; LETTER; LIFESTYLE; MALE; MUSCLE TRAINING; OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; RECTUM HEMORRHAGE; REHABILITATION CARE; WALKING AID; WALKING DIFFICULTY;

ADULT; BLOOD COAGULATION FACTOR INHIBITORS; HEMOPHILIA A; HEMOSTASIS; HEMOSTATICS; HUMANS; MALE; YOUNG ADULT;

EID: 84883052292     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12179     Document Type: Letter

References (10)

1. Blanchette VS, Manco-Johnson MJ. Meeting unmet needs in inhibitor patients. Haemophilia 2010; 16(Suppl. 3): 46-51.
2. Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 2006; 133: 591-605.
3. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
4. Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 2011; 17: 910-9.
5. Young G, Auerswald G, Jimenez-Yuste V et al. When should prophylaxis therapy in inhibitor patients be considered? Haemophilia 2011; 17: e849-57.
6. Leissinger C, Gringeri A, Antmen B et al. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Engl J Med 2011; 365: 1684-92.
7. Young G, McDaniel M, Nugent DJ. Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors. Haemophilia 2005; 11: 203-7.
8. Konkle BA, Ebbesen LS, Erhardtsen E et al. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost 2007; 5: 1904-13.
9. Hoots WK, Ebbesen LS, Konkle BA et al. Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors. Haemophilia 2008; 14: 466-75.
10. Hilgartner MW, Makipernaa A, Dimichele DM. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease. Haemophilia 2003; 9: 261-8.